Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could drive $36–42 upside—read now.

First, let me preface this analysis by stating that I hold some Novo Nordisk A/S (NVO) stock, acquired at around this time last year - and in the 12 months since, my position has halved in value.

Get all the latest on Budget 2026: real‑time headlines, expert analysis, tax changes, sector‑wise expectations and implications for individuals, businesses and the economy on Business Standard ...